BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 27764516)

  • 21. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
    Choi UJ; Jee BK; Lim Y; Lee KH
    Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
    Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
    Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.
    Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J
    Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Metastasis Suppressor KAI1/CD82 in Different Cancers.
    Yan W; Huang J; Zhang Q; Zhang J
    J Oncol; 2021; 2021():9924473. PubMed ID: 34306081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of a metastatic suppressor gene KAI1/CD82 in the diagnosis and prognosis of breast cancer.
    Al-Khater KM; Almofty S; Ravinayagam V; Alrushaid N; Rehman S
    Saudi J Biol Sci; 2021 Jun; 28(6):3391-3398. PubMed ID: 34121877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting CD82/KAI1 for Precision Therapeutics in Surmounting Metastatic Potential in Breast Cancer.
    Viera M; Yip GWC; Shen HM; Baeg GH; Bay BH
    Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of the expression of KAI1/CD82 and PDGFRβ and their impact on glioma progression.
    Paradowski M; Bilinska M; Bar J
    Folia Neuropathol; 2016; 54(3):241-248. PubMed ID: 27764516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KAI1/CD82, a tumor metastasis suppressor.
    Liu WM; Zhang XA
    Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.
    Prabhu VV; Devaraj SN
    J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis.
    Miranti CK
    Cell Signal; 2009 Feb; 21(2):196-211. PubMed ID: 18822372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
    Malik FA; Sanders AJ; Jiang WG
    Histol Histopathol; 2009 Apr; 24(4):519-30. PubMed ID: 19224455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissecting the diverse functions of the metastasis suppressor CD82/KAI1.
    Tsai YC; Weissman AM
    FEBS Lett; 2011 Oct; 585(20):3166-73. PubMed ID: 21875585
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.